Plaintiffs File Petition to Create Pradaxa MDL in Illinois, HarrisMartin Reports
May 31, 2012
DOCUMENTS
- Motion to Transfer
WASHINGTON, D.C. — A motion has been filed before the Judicial Panel on Multidistrict Litigation to create a coordinated MDL docket for all federal personal injury and wrongful death cases involving the drug Pradaxa. In Re: Pradaxa Product Liability Litigation, MDL No. n/a (JPML).
The petition was filed May 30 and seeks transfer of nearly a dozen pending cases, and all future claims, to a centralized docket in the U.S. District Court for the Southern District of Illinois.
Pradaxa is a direct thrombin inhibitor that is used to reduce the risk of stroke and embolism in patients with non-valvular atrial …
UPCOMING CONFERENCES
HarrisMartin's New Jersey Asbestos Litigation Conference
February 27, 2025 - New Brunswick, NJ
Hyatt Regency New Brunswick
HarrisMartin’s Artificial Stone Silicosis Epidemic Litigation Conference
January 10, 2025 - Long Beach, CA
The Westin Long Beach